The Department of Health and Social Care (DHSC) has today (18/10/2022) granted the following initial list of price concessions:
Amisulpride 100mg tablets
Amisulpride 200mg tablets
Cyclizine 50mg/1ml solution for injection ampoules
Dorzolamide 20mg/ml eye drops
Duloxetine 60mg gastro-resistant capsules
Escitalopram 20mg tablets
Ezetimibe 10mg tablets
Naftidrofuryl 100mg capsules
Nebivolol 2.5mg tablets
Paroxetine 20mg tablets
Phenoxymethylpenicillin 250mg tablets
Rasagiline 1mg tablets
Tamsulosin 400microgram / Dutasteride 500microgram capsules
Telmisartan 20mg tablets
Telmisartan 40mg tablets
Telmisartan 80mg tablets
Trospium chloride 20mg tablets
PSNC is seeking improvements to the current price concessions system following significant concerns raised by pharmacy contractors about the unsustainable level of prices, imposed by DHSC in the past few months, for certain medicines and has sent a strong and clear message back to Government that pharmacies cannot subsidise the NHS medicines bill, escalating this within the DHSC and insisting that they find urgent solutions.
To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of PSNC’s recent webinar here.
No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.
PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated October 2022 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.
If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Contractors will be alerted to further updates to the price concession list through our website and via our e-news email. If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.